Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Urszula DoughertyMarc Bissonnette

Abstract

Colonic carcinogenesis deranges growth-regulating epidermal growth factor receptors (EGFR). We previously showed that EGFR signals were up-regulated in human aberrant crypt foci (ACF), putative colon cancer precursors. The azoxymethane model of colon cancer recapitulates many aspects of human colonic tumors. Recent studies indicate that flat dysplastic ACF with increased beta-catenin are tumor precursors in this model. We asked, therefore, if EGFR signals are required for flat dysplastic ACF development and cancer progression. Rats received azoxymethane or saline, and standard chow or chow supplemented with gefitinib, an EGFR inhibitor, for 44 weeks. EGFR signals were quantified in normal colon, flat ACF, and tumors by computerized analysis of immunostains and Western blots. K-ras mutations were assessed by PCR and mRNA for egfr ligands by quantitative real-time PCR. EGFR inhibition with gefitinib decreased the incidence of flat dysplastic ACF from 66% to 36% and tumors from 71% to 22% (P < 0.05). This inhibitor also reduced the overexpressions of cyclin D1 and Cox-2 in flat ACF. Furthermore, in flat ACF, EGFR blockade decreased the up-regulation of c-Jun, FosB, phosphorylated active signal transducers and activators of transcr...Continue Reading

References

Oct 6, 1995·The Journal of Biological Chemistry·C AlbaneseR G Pestell
Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T NakajimaS Akira
Jan 1, 1996·The British Journal of Surgery·R Yoshikawa, J Utsunomiya
Nov 5, 1999·Methods in Molecular Biology·S Rozen, H Skaletsky
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Feb 10, 2000·The American Journal of Pathology·K S ChappleM A Hull
Jul 8, 2000·The Journal of Biological Chemistry·M Haertel-WiesmannL T Williams
Aug 10, 2000·The Journal of Biological Chemistry·J ShaoR N DuBois
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Songyun ZhuRobert C Smart
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Reade B RobertsDavid W Threadgill
Mar 20, 2002·The Journal of Biological Chemistry·Kotha SubbaramaiahAndrew J Dannenberg
Jul 23, 2002·Nature Cell Biology·Leon O MurphyJohn Blenis
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Hanlin L WangJohn Hart
Mar 4, 2003·Gastroenterology·Gregory P BoivinRobert J Coffey
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick A AdegboyegaDon W Powell
Oct 12, 2004·Hematology/oncology Clinics of North America·Lee M Ellis
Jul 14, 2005·Gastroenterology·Xinping TanSatdarshan P S Monga
Jul 23, 2005·Neoplasia : an International Journal for Oncology Research·Florian M CorvinusKarlheinz Friedrich
Aug 12, 2005·International Journal of Cancer. Journal International Du Cancer·Jan Erik PaulsenJan Alexander
Dec 27, 2005·Gene·Nicola NormannoDavid S Salomon
Mar 25, 2006·Journal of Clinical Pathology·M TretiakovaX J Yang
Aug 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shirin Khambata-FordDavid J Mauro

❮ Previous
Next ❯

Citations

Aug 21, 2013·Journal of Gastrointestinal Cancer·Liu YangAdhip P N Majumdar
May 22, 2013·European Journal of Medicinal Chemistry·Sashikanth BanappagariSeetharama Satyanarayanajois
Apr 4, 2012·Journal of Medicinal Chemistry·Benson G OngaroraM Graça H Vicente
Feb 4, 2012·American Journal of Physiology. Gastrointestinal and Liver Physiology·James YooEnrique Rozengurt
Nov 12, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Urszula DoughertyMarc Bissonnette
Dec 16, 2011·World Journal of Gastroenterology : WJG·Beatriz PagánCaroline B Appleyard
Mar 3, 2009·Annals of the New York Academy of Sciences·C BerasainM A Avila
Jun 2, 2011·International Journal of Cancer. Journal International Du Cancer·James M BugniCharalabos Pothoulakis
Nov 23, 2010·Phytotherapy Research : PTR·Myung Sun LeeJi Yeon Kim
Aug 15, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Ya-di GengLing-Yi Kong
Jul 17, 2015·Clinical and Translational Gastroenterology·Juan ZhouThomas D Wang
Sep 8, 2009·Journal of Zhejiang University. Science. B·Jian-zhen ShanSu-zhan Zhang
Aug 7, 2008·Journal of Experimental & Clinical Cancer Research : CR·Qing LuTao Shan
Jul 25, 2015·Journal of Experimental & Clinical Cancer Research : CR·Bassem RefaatAthar Khojah
Nov 30, 2011·Best Practice & Research. Clinical Gastroenterology·Riccardo SolimandoLuigi Ricciardiello
Jan 1, 2011·Cancers·Dingzhi WangRaymond N Dubois
Oct 21, 2017·Chemical Biology & Drug Design·Tyrslai M WilliamsSeetharama D Jois
Dec 15, 2010·Journal of the Korean Society of Coloproctology·Yoon Dae HanChan Heun Park
Mar 5, 2011·Cancer Prevention Research·Robert E CarrollDean E Brenner
Sep 13, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Urszula DoughertyMarc Bissonnette
Aug 5, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Reba MustafiMarc Bissonnette
Apr 18, 2017·Bioconjugate Chemistry·Ning ZhaoM Graça H Vicente

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society
Robert E CarrollTerry G Unterman
Journal of Cell Science
Erik G HofmanPaul M P van Bergen En Henegouwen
© 2022 Meta ULC. All rights reserved